Advertisement

Mycopathologia

, Volume 65, Issue 1–3, pp 169–176 | Cite as

The in vitro interactions of candida albicans with nonspecific serum proteins

  • H. F. Hasenclever
Mechanisms of Pathogenicity Among Zoopayhogens

Conclusions

Iron has a pivotal role in serum inhibition and filamentation. That there may be an inverse relationship between inhibition and filamentation is suggested by the observations that free serum iron abolishes inhibition and stimulates filamentation.

Evidence indicates that filamentation results from the interaction of substrates, growth conditions, and temperature, rather than from a single factor. Filamentation occurs during clumping and appears to be necessary for the manifestation of this later process, but any further relationship is unknown.

Opsonins seem to be a part of the complement system or their function at least is dependent upon complement activity. Their interaction with surface antigens form chemotactic stimulants but their contribution to the phagocytic destruction of C. Albicans is unclear. All of these serum-Candida interactions are in vitro observations. Although opsonization and phagocytosis probably play a vital role in the in vivo defenses against invading Candida, the contribution of these other interactions to host resistance remain unknown.

Keywords

Iron Growth Condition Candida Pivotal Role Inverse Relationship 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barlow, A. J. E., T. Aldersley & F. W. Chattaway. 1974. Factors present in serum and seminal plasma which promote germtube formation and mycelial growth of Candida albicans. J. Gen. Microbiol. 82: 261–272.Google Scholar
  2. 2.
    Brune, K., M. S. Leffel & J. K. Spitznagel. 1972. Microbial activity of peroxidaseless chicken heterophile leucocytes. Infect. Immun. 5: 283–287.Google Scholar
  3. 3.
    Caroline, L., C. L. Taschdjean, P. J. Kozinn & A. L. Schade. 1964. Reversal of serum fungistasis by addition of iron. J. Invest. Derm. 42: 415–419.Google Scholar
  4. 4.
    Chattaway, F. W., R. Bischop, M. R. Holmes, F. C. Olds & A. J. E. Barlow. 1972. Enzyme activities associated with carbohydrate synthesis and breakdown in the yeast and mycelial forms of Candida albicans J. Gen. Microbiol. 75: 97–109.Google Scholar
  5. 5.
    Chattaway, F. W., J. O'Reilly, A. J. E. Barlow & T. Aldersley. 1976. Induction of the mycelial form of Candida albicans by hydrolysates of peptides from seminal plasma. J. Gen. Microbiol. 96: 317–322.Google Scholar
  6. 6.
    Chilgren, R. A., R. Hong & P. G. Quie. 1968. Human serum interactions with Candida albicans. J. Immunol. 101: 128–132.Google Scholar
  7. 7.
    Dabrowa, N., S. S. S. Taxer & D. H. Howard. 1976. Germination of Candida albicans induced by proline. Infect. Immun. 13: 830–835.Google Scholar
  8. 8.
    Davies, R. R. & T. J. V. Denning. 1972. Candida albicans and the fungicidal activity of the blood. Sabouraudia 10: 301–312.Google Scholar
  9. 9.
    Denning, T. J. V. & R. R. Davies. 1973. Candida albicans and the chemotaxis of polymorphonuclear neutrophils. Sabouraudia 11: 210–221.Google Scholar
  10. 10.
    Dobias, D. 1964. Specific and nonspecific immunity in Candida infections. Experimental studies of the role of Candida cell constituents and review of literature. Acta Med. Scand. 176 (Suppl. 421) 1–79.Google Scholar
  11. 11.
    Esterly, N. B., S. R. Brammer & R. G. Crounse. 1967. Relationship of transferrin and iron to serum inhibition of Candida albicans. J. Invest. Derm. 49: 431–442.Google Scholar
  12. 12.
    Fahlberg, W. J., C. D. Dukes & R. K. Guthrie. 1957. Rapid classification of Candida (Monilia) albicans. J. Invest. Derm. 29: 111–118.Google Scholar
  13. 13.
    Hasenclever, H. F. & W. O. Mitchell. 1963. Endotoxininduced tolerance to toxic manifestations of Candida albicans. J. Bact. 85: 1088–1093.Google Scholar
  14. 14.
    Hasenclever, H. F. & W. O. Mitchell. 1963. Acquired immunity to candidiasis in mice. J. Bact. 86: 401–406.Google Scholar
  15. 15.
    Hendry, A. T. 1972. Inhibition of catalase activity of Candida albicans by serum. Sabouraudia 10: 193–204.Google Scholar
  16. 16.
    Hendry, A. T. & A. Bakerspigel. 1969. Factors affecting serum inhibited growth of Candida albicans and Cryptococcus neoformans. Sabouraudia 7: 219–229.Google Scholar
  17. 17.
    Holmberg, C. G. & C. B. Laurell. 1945. Studies on the capacity of serum to bind iron. Acta Physiol. Scand. 10: 307–319.Google Scholar
  18. 18.
    Hu, F., C. S. Livingood, P. Johnson & C. M. Pomerat. 1954. Tissue culture studies on human skin. Arch. Derm. (Chicago) 70: 1–15.Google Scholar
  19. 19.
    Johnson, S. A. M. 1954. Candida (Monilia) albicans. Arch. Derm. (Chicago). 70: 49–60.Google Scholar
  20. 20.
    Joshi, K. B., J. B. Gavin & D. A. Bremner. 1973. The formation of germ tubes by Candida albicans in various peptone media. Sabouraudia 11: 259–262.Google Scholar
  21. 21.
    Land, G. A., W. C. McDonald, R. L. Stjernholm & L. Friedman. 1975. Factors affecting filamentation in Candida albicans: Relationship of the uptake and distribution of proline to morphogenesis. Infect. Immun. 11: 1014–1023.Google Scholar
  22. 22.
    Landau, J. W., N. Dabrowa & V. D. Newcomer. 1965. The rapid formation in serum of filaments by Candida albicans. J. Invest. Derm. 44: 171–179.Google Scholar
  23. 23.
    Landau, J. W., N. Dabrowa, V. D. Newcomer & J. R. Rowe. 1964. The relationship of serum transferrin and iron to the rapid formation of germ tubes by Candida albicans. J. Invest. Derm. 43: 473–482.Google Scholar
  24. 24.
    Lee, K. L., H. P. Buckley & C. C. Campbell. 1975. An amino acid synthetic medium for the development of mycelial and yeast form of Candida albicans. Sabouraudia 13: 148–153.Google Scholar
  25. 25.
    Lehrer, R.I. 1972. Functional aspects of a second mechanism of candidicidal activity by human neutrophils. J. Clin. Invest. 51: 2566–2572.Google Scholar
  26. 26.
    Lehrer, R. I. & M. J. Cline. 1969. Interactions of Candida albicans with human leucocytes and serum. J. Bact. 98: 996–1004.Google Scholar
  27. 27.
    Louria, D. B. & R. G. Brayton. 1964. A substance in blood lethal for Candida albicans. Nature 201–309.Google Scholar
  28. 28.
    Louria, D. B., R. G. Brayton & G. Finkel. 1963. Studies on the pathogenesis of experimental Candida albicans infections in mice. Sabouraudia 2: 271–283.Google Scholar
  29. 29.
    Louria, D. B., D. Shannon, G. Johnson, L. Caroline, A. Okas & C. L. Taschdjean. 1967. The susceptibility to moniliasis in children with endocrine hypofunction. Trans. Assoc. Amer. Physician 80: 236–248.Google Scholar
  30. 30.
    Louria, D. B., J. K. Smith, R. G. Brayton & M. Buse. 1972. Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations. J. Infect. Dis. 125: 102–114.Google Scholar
  31. 31.
    Mackenzie, D. W. R. 1958. Studies on the biology of pathogenic fungi. Ph. D. Thesis. Edinburgh.Google Scholar
  32. 32.
    Mackenzie, D. W. R. 1962. Serum tube identification of Candida albicans. J. Clin. Path. 15: 563–565.Google Scholar
  33. 33.
    Mardon D. N., S. K. Hurst & E. Balish. 1971. Serum-tube production by Candida albicans in a minimal liquid culture media. Can. J. Microbiol. 17: 851–856.Google Scholar
  34. 34.
    Miller, M. E. & U. R. Nilsson. 1970. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). New Engl. J. Med. 282: 354–358.Google Scholar
  35. 35.
    Morelli, R. & L. T. Rosenberg. 1971. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leucocytes. J. Immunol. 107: 476–480.Google Scholar
  36. 36.
    Newton, A., E. D. Shaw, C. S. Goode & F. O. Riggall. 1960. Identification of Candida albicans. J. Invest. Derm. 35: 123.Google Scholar
  37. 37.
    Oh, M.-H. K., G. E. Rodey, R. A. Goode, R. A. Chilgren & P. G. Quie. 1968. Defective candicidal capacity of polymorphonuclear leucocytes in chronic granulomatous disease of childhood. J. Ped. 75: 300–303.Google Scholar
  38. 38.
    Preisler, H. D., H. F. Hasenclever, E. S. Henderson, J. K. Smith & D. B. Louria. 1972. A prospective study of anti-Candida interfering factor in leukemia patients. Cancer 30: 294–299.Google Scholar
  39. 39.
    Ray, T. L. & K. D. Wuepper. 1976. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J. Invest. Derm. 67: 700–703.Google Scholar
  40. 40.
    Reynolds, R. & A. Braude. 1956. The filament-inducing property of blood for Candida albicans: Its nature and significance. Clin. Res. Proc. 4: 40.Google Scholar
  41. 41.
    Ridley, M. F. 1960. A comparison of methods for identification of Candida albicans. Aust. J. Derm. 5: 209–213.Google Scholar
  42. 42.
    Roth, F. J., Jr., C. C. Boyd, S. Sagami & H. Blank. 1959. An evaluation of the fungistatic activity of serum. J. Invest. Derm. 32: 549–556.Google Scholar
  43. 43.
    Roth, F. J., Jr. & M. I. Goldstein. 1961. Inhibition of growth of pathogenic yeasts by human serum. J. Invest. Derm. 36: 383–387.Google Scholar
  44. 44.
    Schade, A. L. & L. Caroline. 1946. An iron binding component in human blood plasma. Science 104: 340–341.Google Scholar
  45. 45.
    Smith, J. K. & D. B. Louria. 1972. Anti-Candia factors in serum and their inhibitors. II. Identification of a Candidaclumping factor and the influence of the immune response on the morphology of Candida and on anti-Candida activity of serum in rabbits. J. Infect. Dis. 125: 115–122.Google Scholar
  46. 46.
    Summers, D. F. & H. F. Hasenclever. 1964. In vitro inhibition of yeast growth by mouse ascites fluid and serum. J. Bact. 87: 1–7.Google Scholar
  47. 47.
    Taschdjean, C. L., J. J. Burchall & P. J. Kozinn. 1960. Rapid identification of Candida albicans by filamentation on serum and serum substitutes. A. M. A. J. Dis. Child. 99: 212–215.Google Scholar
  48. 48.
    Taschdjean, C. L. & P. J. Kozinn. 1961. Metabolic studies of the tissue phase of Candida albicans induced in vitro. Sabouraudia 1: 73–82.Google Scholar
  49. 49.
    Wain, W. H., M. F. Price & R. A. Cawson. 1975. A reevaluation of the effect of cystein on Candida albicans. Sabouraudia 13: 74–82.Google Scholar
  50. 50.
    Weinberg, E. D. 1974. Iron and susceptibility to infectious desease. Science 184: 952–956.Google Scholar

Copyright information

© Dr. W. Junk bv - Publishers 1978

Authors and Affiliations

  • H. F. Hasenclever
    • 1
  1. 1.U.S. Department of Health, Education, and Welfare, Public Health ServiceNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Rocky Mountain LaboratoryHamiltonUSA

Personalised recommendations